Skip to content
Sotigalimab
Sotigalimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
15 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MelanomaD008545637
Non-small-cell lung carcinomaD002289313
Pancreatic neoplasmsD010190EFO_0003860C25323
NeoplasmsD009369C80212
Lung neoplasmsD008175C34.90111
Esophageal neoplasmsD004938C1511
SarcomaD01250911
Ovarian neoplasmsD010051EFO_0003893C5611
Squamous cell carcinomaD002294111
Adenosquamous carcinomaD018196111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Renal cell carcinomaD00229222
Colorectal neoplasmsD01517911
Pancreatic ductal carcinomaD02144111
GlioblastomaD005909EFO_000051511
MedulloblastomaD00852711
EpendymomaD00480611
AstrocytomaD001254EFO_000027111
Diffuse intrinsic pontine gliomaD00008044311
Urologic neoplasmsD014571C64-C6811
Head and neck neoplasmsD00625811
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameSOTIGALIMAB
INNsotigalimab
Description
Sotigalimab is an antibody pharmaceutical. It is currently being investigated in clinical studies.
Classification
Antibody
Drug classmonoclonal antibodies
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL4297888
ChEBI ID
PubChem CID
DrugBank
UNII IDJEA93WJ5DG (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 130 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details